Works matching AU Shi, Harry

Results: 29

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1640, doi. 10.1111/dom.14385

By:

Lingvay, Ildiko;
Greenberg, Michelle;
Gallo, Silvina;
Shi, Harry;
Liu, Jie;
Gantz, Ira

Publication type:

Article

Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1027, doi. 10.1111/dom.13631

By:

Gallo, Silvina;
Charbonnel, Bernard;
Goldman, Allison;
Shi, Harry;
Huyck, Susan;
Darekar, Amanda;
Lauring, Brett;
Terra, Steven G.

Publication type:

Article

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 520, doi. 10.1111/dom.13103

By:

Rosenstock, Julio;
Frias, Juan;
Páll, Dénes;
Charbonnel, Bernard;
Pascu, Raluca;
Saur, Didier;
Darekar, Amanda;
Huyck, Susan;
Shi, Harry;
Lauring, Brett;
Terra, Steven G.

Publication type:

Article

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study.

Published in:

European Heart Journal, 2014, v. 35, n. 34, p. 2295

By:

Montalescot, Gilles;
Pitt, Bertram;
Lopez de Sa, Esteban;
Hamm, Christian W.;
Flather, Marcus;
Verheugt, Freek;
Shi, Harry;
Turgonyi, Eva;
Orri, Miguel;
Vincent, John;
Zannad, Faiez

Publication type:

Article

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.

Published in:

European Heart Journal, 2013, v. 34, n. 36, p. 2823, doi. 10.1093/eurheartj/eht247

By:

Collier, Timothy J.;
Pocock, Stuart J.;
McMurray, John J.V.;
Zannad, Faiez;
Krum, Henry;
van Veldhuisen, Dirk J.;
Swedberg, Karl;
Shi, Harry;
Vincent, John;
Pitt, Bertram

Publication type:

Article

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?

Published in:

European Heart Journal, 2010, v. 31, n. 21, p. 2650, doi. 10.1093/eurheartj/ehq133

By:

Deanfield, John E.;
Sellier, Phillipe;
Thaulow, Erik;
Bultas, Jan;
Yunis, Carla;
Shi, Harry;
Buch, Jan;
Beckerman, Bruce

Publication type:

Article

Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure: The CAMELOT Study: A Randomized Controlled Trial.

Published in:

JAMA: Journal of the American Medical Association, 2004, v. 292, n. 18, p. 2217, doi. 10.1001/jama.292.18.2217

By:

Nissen, Steven E.;
Tuzcu, E. Murat;
Libby, Peter;
Thompson, Paul D.;
Ghali, Magdi;
Garza, Dahlia;
Berman, Lance;
Shi, Harry;
Buebendorf, Ethel;
Topol, Eric J.

Publication type:

Article

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

Published in:

European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 792, doi. 10.1002/ejhf.688

By:

Rossignol, Patrick;
Girerd, Nicolas;
Bakris, George;
Vardeny, Orly;
Claggett, Brian;
McMurray, John J. V.;
Swedberg, Karl;
Krum, Henry;
van Veldhuisen, Dirk J.;
Shi, Harry;
Spanyers, Sean;
Vincent, John;
Fay, Renaud;
Lamiral, Zohra;
Solomon, Scott D.;
Zannad, Faiez;
Pitt, Bertram

Publication type:

Article

Amlodipine/Atorvastatin Single-Pill Therapy for Blood Pressure and Lipid Goals in African Americans: Influence of the Metabolic Syndrome and Type 2 Diabetes Mellitus.

Published in:

Journal of Clinical Hypertension, 2009, v. 11, n. 10, p. 585, doi. 10.1111/j.1751-7176.2009.00062.x

By:

Ferdinand, Keith C.;
Flack, John M.;
Saunders, Elijah;
Victor, Ronald;
Watson, Karol;
Kursun, Attila;
Jamieson, Michael J.;
Shi, Harry

Publication type:

Article

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.

Published in:

Clinical Research in Cardiology, 2018, v. 107, n. 12, p. 1192, doi. 10.1007/s00392-018-1373-5

By:

Ferreira, João Pedro;
Barros, António;
Pitt, Bertram;
Montalescot, Gilles;
de Sa, Esteban Lopez;
Hamm, Christian W.;
Flather, Marcus;
Verheugt, Freek;
Shi, Harry;
Leite-Moreira, Adelino;
Vincent, John;
Rossignol, Patrick;
Zannad, Faiez

Publication type:

Article

Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study.

Published in:

Clinical Research in Cardiology, 2018, v. 107, n. 1, p. 49, doi. 10.1007/s00392-017-1157-3

By:

Ferreira, João Pedro;
Duarte, Kévin;
Montalescot, Gilles;
Pitt, Bertram;
de Sa, Esteban Lopez;
Hamm, Christian W.;
Flather, Marcus;
Verheugt, Freek;
Shi, Harry;
Turgonyi, Eva;
Orri, Miguel;
Rossignol, Patrick;
Vincent, John;
Zannad, Faiez

Publication type:

Article

Discovery of metamorphic diamonds in central China: an indication of a > 4000-km-long zone of deep subduction resulting from multiple continental collisions.

Published in:

Terra Nova, 2003, v. 15, n. 6, p. 370, doi. 10.1046/j.1365-3121.2003.00511.x

By:

Jingsui Yang, Erwan;
Zhiqin Xu, Erwan;
Dobrzhinetskaya, Larissa F.;
Green II, Harry W.;
Xianzhi Pei, Harry W.;
Rendeng Shi, Harry W.;
Cailai Wu, Harry W.;
Wooden, Joseph L.;
Jianxin Zhang;
Yusheng Wan;
Haibing Li

Publication type:

Article

Relationship of Early Dressing Change, Ambulation, and Early Discharge in Lower Extremity Grafted Burn Wounds.

Published in:

Journal of Burn Care & Research, 2023, v. 44, p. S21, doi. 10.1093/jbcr/irad045.025

By:

Toledo, Sandor;
Blome-Eberwein, Sigrid;
Barros De Souza, Cesar;
Shi, Harry;
Watanabe, Miname;
Anderson, Morgan

Publication type:

Article

Evaluation of the Efficacy and Safety of Bazedoxifene/Conjugated Estrogens for Secondary Outcomes Including Vasomotor Symptoms in Postmenopausal Women by Years Since Menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) Trials.

Published in:

2014

By:

Pinkerton, JoAnn V.;
Abraham, Lucy;
Bushmakin, Andrew G.;
Cappelleri, Joseph C.;
Racketa, Jill;
Shi, Harry;
Chines, Arkadi A.;
Mirkin, Sebastian

Publication type:

Journal Article

Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy.

Published in:

Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02591-y

By:

Takeuchi, Tsutomu;
Fleischmann, Roy;
Iikuni, Noriko;
Shi, Harry;
Soma, Koshika;
Paulissen, Jerome;
Hirose, Tomohiro;
Smolen, Josef S.

Publication type:

Article

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.

Published in:

Arthritis Research & Therapy, 2020, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13075-020-02324-7

By:

Strand, Vibeke;
Kaine, Jeffrey;
Alten, Rieke;
Wallenstein, Gene;
Diehl, Annette;
Shi, Harry;
Germino, Rebecca;
Murray, Christopher W.

Publication type:

Article

Amlodipine Added to Quinapril vs Quinapril Alone for the Treatment of Hypertension in Diabetes: The Amlodipine in Diabetes (ANDI) Trial.

Published in:

Journal of Clinical Hypertension, 2007, v. 9, n. 2, p. 120, doi. 10.1111/j.1524-6175.2007.06949.x

By:

Tobe, Sheldon;
Kawecka-Jaszcz, Kalina;
Zannad, Faiez;
Vetrovec, George;
Patni, Rajiv;
Shi, Harry

Publication type:

Article

Amlodipine/Atorvastatin Single-Pill Therapy Improves Blood Pressure and Lipid Goal Attainment in African-Americans with Diabetes Mellitus (DM) and Metabolic Syndrome (MS): Findings from the CAPABLE Trial.

Published in:

Diabetes, 2007, v. 56, p. A562

By:

Ferdinand, Keith C.;
Haffner, Steven M.;
Watson, Karol;
Flack, John M.;
Saunders, Elijah;
Victor, Ronald;
Tarasenko, Lisa;
Jamieson, Michael J.;
Shi, Harry

Publication type:

Article

Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension

Published in:

American Journal of Hypertension, 2002, v. 15, n. 1, p. 31

By:

Grimm Jr., Richard H.;
Black, Henry;
Rowen, Randall;
Lewin, Andrew;
Shi, Harry;
Ghadanfar, Mathieu

Publication type:

Article

P-242: A multicenter single-blind trial evaluating the efficacy of amlodipine in patients with severe hypertension (JNC stage 3)*.

Published in:

American Journal of Hypertension, 2001, v. 14, p. 109A, doi. 10.1016/S0895-7061(01)01432-7

By:

Flack, John M.;
Garza, Dahlia;
Shi, Harry

Publication type:

Article

P-238: A sequential design study to compare the antihypertensive effect of amlodipine to nifedipine GITS in patients with multiple drug requiring hypertension.

Published in:

American Journal of Hypertension, 2001, v. 14, p. 108A, doi. 10.1016/S0895-7061(01)01428-5

By:

Preston, Richard A.;
Alonso, Alberto;
Baltodano, Neyton M.;
Shi, Harry;
Scott, Rob

Publication type:

Article

The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin*.

Published in:

Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 4, p. 414, doi. 10.1016/S0009-9236(98)90036-4

By:

Cato, Allen;
Cavanaugh, John;
Shi, Harry;
Hsu, Ann;
Leonard, John;
Granneman, Richard

Publication type:

Article

Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics*.

Published in:

Clinical Pharmacology & Therapeutics, 1996, v. 60, n. 1, p. 48, doi. 10.1016/S0009-9236(96)90166-6

By:

Wong, Shekman L.;
Cavanaugh, John;
Shi, Harry;
Awni, Walid M.;
Granneman, G. Richard

Publication type:

Article

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

Published in:

2017

By:

Rossignol, Patrick;
Girerd, Nicolas;
Bakris, George;
Vardeny, Orly;
Claggett, Brian;
McMurray, John J.V.;
Swedberg, Karl;
Krum, Henry;
van Veldhuisen, Dirk J.;
Shi, Harry;
Spanyers, Sean;
Vincent, John;
Fay, Renaud;
Lamiral, Zohra;
Solomon, Scott D.;
Zannad, Faiez;
Pitt, Bertram

Publication type:

journal article

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

Published in:

European Journal of Heart Failure, 2012, v. 14, n. 8, p. 909, doi. 10.1093/eurjhf/hfs067

By:

Preiss, David;
van Veldhuisen, Dirk J.;
Sattar, Naveed;
Krum, Henry;
Swedberg, Karl;
Shi, Harry;
Vincent, John;
Pocock, Stuart J.;
Pitt, Bertram;
Zannad, Faiez;
McMurray, John J.V.

Publication type:

Article

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

Published in:

European Journal of Heart Failure, 2010, v. 12, n. 6, p. 617, doi. 10.1093/eurjhf/hfq049

By:

Zannad, Faiez;
McMurray, John J.V.;
Drexler, Helmut;
Krum, Henry;
van Veldhuisen, Dirk J.;
Swedberg, Karl;
Shi, Harry;
Vincent, John;
Pitt, Bertram

Publication type:

Article

Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 2, p. 375, doi. 10.1007/s40744-022-00511-3

By:

Fleischmann, Roy;
Haraoui, Boulos;
Buch, Maya H.;
Gold, David;
Sawyerr, Gosford;
Shi, Harry;
Diehl, Annette;
Lee, Kristen

Publication type:

Article

785-P: Ertugliflozin (ERTU) Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients with Type 2 Diabetes (T2D): An Analysis From VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-785-P

By:

DAGOGO-JACK, SAMUEL;
FREDERICH, ROBERT;
CHARBONNEL, BERNARD;
LIU, JIE;
CANNON, CHRISTOPHER P.;
SHI, HARRY;
MCGUIRE, DARREN K.;
CHERNEY, DAVID;
COSENTINO, FRANCESCO;
SHIH, WEICHUNG J.;
MASIUKIEWICZ, URSZULA;
GANTZ, IRA;
PRATLEY, RICHARD E.

Publication type:

Article

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. 2042, doi. 10.1210/clinem/dgac764

By:

Dagogo-Jack, Samuel;
Frederich, Robert;
Jie Liu;
Cannon, Christopher P.;
Shi, Harry;
Cherney, David Z. I.;
Cosentino, Francesco;
Masiukiewicz, Urszula;
Gantz, Ira;
Pratley, Richard E.

Publication type:

Article

Works matching AU Shi, Harry

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy.

Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial.

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study.

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?

Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure: The CAMELOT Study: A Randomized Controlled Trial.

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

Amlodipine/Atorvastatin Single-Pill Therapy for Blood Pressure and Lipid Goals in African Americans: Influence of the Metabolic Syndrome and Type 2 Diabetes Mellitus.

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.

Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study.

Discovery of metamorphic diamonds in central China: an indication of a > 4000-km-long zone of deep subduction resulting from multiple continental collisions.

Relationship of Early Dressing Change, Ambulation, and Early Discharge in Lower Extremity Grafted Burn Wounds.

Evaluation of the Efficacy and Safety of Bazedoxifene/Conjugated Estrogens for Secondary Outcomes Including Vasomotor Symptoms in Postmenopausal Women by Years Since Menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) Trials.

Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy.

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.

Amlodipine Added to Quinapril vs Quinapril Alone for the Treatment of Hypertension in Diabetes: The Amlodipine in Diabetes (ANDI) Trial.

Amlodipine/Atorvastatin Single-Pill Therapy Improves Blood Pressure and Lipid Goal Attainment in African-Americans with Diabetes Mellitus (DM) and Metabolic Syndrome (MS): Findings from the CAPABLE Trial.

Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension

P-242: A multicenter single-blind trial evaluating the efficacy of amlodipine in patients with severe hypertension (JNC stage 3)<sup>*</sup>.

P-238: A sequential design study to compare the antihypertensive effect of amlodipine to nifedipine GITS in patients with multiple drug requiring hypertension.

The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin<sup>*</sup>.

Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics<sup>*</sup>.

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate.

785-P: Ertugliflozin (ERTU) Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients with Type 2 Diabetes (T2D): An Analysis From VERTIS CV.

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.